4.5 Article

Characterization of the epithelial cell adhesion molecule (EpCAM) plus cell population in hepatocellular carcinoma cell lines

期刊

CANCER SCIENCE
卷 101, 期 10, 页码 2145-2155

出版社

WILEY-BLACKWELL
DOI: 10.1111/j.1349-7006.2010.01661.x

关键词

-

类别

资金

  1. Ministry of Education, Culture, Sports, Science and Technology of Japan
  2. Japan Society for the Promotion of Science

向作者/读者索取更多资源

Accumulating evidence suggests that cancer stem cells (CSC) play an important role in tumorigenicity. Epithelial cell adhesion molecule (EpCAM) is one of the markers that identifies tumor cells with high tumorigenicity. The expression of EpCAM in liver progenitor cells prompted us to investigate whether CSC could be identified in hepatocellular carcinoma (HCC) cell lines. The sorted EpCAM+ subpopulation from HCC cell lines showed a greater colony formation rate than the sorted EpCAM- subpopulation from the same cell lines, although cell proliferation was comparable between the two subpopulations. The in vivo evaluation of tumorigenicity, using supra-immunodeficient NOD/scid/gamma cnull (NOG) mice, revealed that a smaller number of EpCAM+ cells (minimum 100) than EpCAM- cells was necessary for tumor formation. The bifurcated differentiation of EpCAM+ cell clones into both EpCAM+ and EpCAM- cells was obvious both in vitro and in vivo, but EpCAM- clones sustained their phenotype. These clonal analyses suggested that EpCAM+ cells may contain a multipotent cell population. Interestingly, the introduction of exogenous EpCAM into EpCAM+ clones, but not into EpCAM- clones, markedly enhanced their tumor-forming ability, even though both transfectants expressed a similar level of EpCAM. Therefore, the difference in the tumor-forming ability between EpCAM+ and EpCAM- cells is probably due to the intrinsic biological differences between them. Collectively, our results suggest that the EpCAM+ population is biologically quite different from the EpCAM- population in HCC cell lines, and preferentially contains a highly tumorigenic cell population with the characteristics of CSC. (Cancer Sci 2010).

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Medicine, General & Internal

Long-Term Efficacy and Safety of Rifaximin in Japanese Patients with Hepatic Encephalopathy: A Multicenter Retrospective Study

Hideto Kawaratani, Yasuteru Kondo, Ryoji Tatsumi, Naoto Kawabe, Norikazu Tanabe, Akira Sakamaki, Kazuo Okumoto, Yoshihito Uchida, Kei Endo, Takumi Kawaguchi, Tsunekazu Oikawa, Yoji Ishizu, Shuhei Hige, Taro Takami, Shuji Terai, Yoshiyuki Ueno, Satoshi Mochida, Yasuhiro Takikawa, Takuji Torimura, Tomokazu Matsuura, Masatoshi Ishigami, Kazuhiko Koike, Hitoshi Yoshiji

Summary: This study found that long-term treatment with rifaximin is effective and safe for patients with hepatic encephalopathy. Ammonia levels significantly improved after 3 months of treatment and remained improved until 12 months. There were no serious adverse events reported, and the incidence of overt hepatic encephalopathy was low.

JOURNAL OF CLINICAL MEDICINE (2022)

Article Gastroenterology & Hepatology

Trends in drug prescriptions for type 2 diabetes, hypertension, and dyslipidemia among adults with non-alcoholic fatty liver disease

Toshiya Machida, Taku Obara, Makoto Miyazaki, Jun Inoue, Nariyasu Mano

Summary: Patients with comorbid non-alcoholic fatty liver disease (NAFLD) and/or non-alcoholic steatohepatitis (NASH) tend to be prescribed specific drugs for type 2 diabetes, hypertension, and dyslipidemia. However, the differences in prescription ratios are not considerable, and further investigation is needed to confirm the effects of these drugs on the prognosis of patients with NAFLD or NASH.

ANNALS OF HEPATOLOGY (2022)

Article Gastroenterology & Hepatology

Trends of hepatitis B virus genotype distribution in chronic hepatitis B patients in Japan

Kazumasa Sakamoto, Kiyoaki Ito, Hiroshi Yotsuyanagi, Hiroshi Yatsuhashi, Yasuhito Tanaka, Shuhei Hige, Yasuhiro Takikawa, Yoshiyuki Ueno, Kazuhide Yamamoto, Fumio Imazeki, Jun Inoue, Masayuki Kurosaki, Takeji Umemura, Hidenori Toyoda, Eiji Mita, Kojiro Michitaka, Tatsuji Maeshiro, Norie Yamada, Atsushi Suetsugu, Miwa Kawanaka, Yuya Seko, Kentaro Matsuura, Akinori Okumura, Yoshitaka Fukuzawa, Masaya Sugiyama, Masashi Mizokami, Masashi Yoneda

Summary: This study found that the distribution of HBV genotypes among CHB patients in Japan has changed over time, with an increase in genotype A among young adults and a shift of genotypes B and C towards older age groups. This data provides important baseline information for comparative studies on the impact of universal HBV vaccination.

JOURNAL OF GASTROENTEROLOGY (2022)

Letter Gastroenterology & Hepatology

Reply: Serum pancreatic amylase and colorectal adenoma: From clinical research to practice

Y. Sasaki, Y. Abe, S. Nishise, Y. Ueno

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2022)

Article Gastroenterology & Hepatology

Liver steatosis and fibrosis markers? association with cardiovascular and renal damage in Japanese adults: The TMM BirThree cohort study

Toshiya Machida, Taku Obara, Mami Ishikuro, Keiko Murakami, Fumihiko Ueno, Aoi Noda, Tomomi Onuma, Fumiko Matsuzaki, Jun Inoue, Shinichi Kuriyama, Nariyasu Mano

Summary: This study aimed to examine the association between liver steatosis and fibrosis and atherosclerosis and chronic kidney disease. The results showed that a higher fatty liver index was associated with chronic kidney disease, independent of other risk factors. Further research is needed to understand the causal relationship between liver fat accumulation and chronic kidney disease.

ANNALS OF HEPATOLOGY (2023)

Article Medicine, General & Internal

Duodenal Variceal Rupture during Atezolizumab and Bevacizumab Treatment for Hepatocellular Carcinoma

Mio Tsuruoka, Jun Inoue, Keishi Ouchi, Kaname Uno, Hideaki Itami, Masashi Ninomiya, Tomoaki Iwata, Akitoshi Sano, Kosuke Sato, Masazumi Onuki, Satoko Sawahashi, Tomoyuki Koike, Atsushi Masamune

Summary: We report a rare case of duodenal varices rupture in an 87-year-old man during chemotherapy with atezolizumab and bevacizumab (ATZ/BV) for hepatocellular carcinoma. Emergency esophagogastroduodenoscopy (EGD) revealed massive bleeding of a ruptured varix in the horizontal portion of the duodenum. Successful hemostasis was achieved through endoscopic injection sclerotherapy. Although esophageal varices rupture has been reported with ATZ/BV treatment, this is the first case of duodenal varices rupture. Regular evaluation of both duodenal and esophageal varices is recommended before ATZ/BV treatment.

INTERNAL MEDICINE (2023)

Article Multidisciplinary Sciences

Association between lack of sexual interest and all-cause mortality in a Japanese general population: The Yamagata prospective observational study

Kaori Sakurada, Tsuneo Konta, Narumi Murakami, Naoko Kosugi, Takafumi Saito, Masafumi Watanabe, Kenichi Ishizawa, Yoshiyuki Ueno, Takamasa Kayama

Summary: This study found that lack of sexual interest may be a risk factor for all-cause mortality in Japanese males over 40 years old.

PLOS ONE (2022)

Article Medical Laboratory Technology

Evaluation of a Capillary Microsampling Device for Analyzing Plasma Lenvatinib Concentration in Patients With Hepatocellular Carcinoma

Akihiro Saito, Masafumi Kikuchi, Yuko Matsumoto, Erina Sugawara, Gesshu Takao, Hayato Inomata, Akane Takahashi, Yuji Sato, Masaki Kumondai, Yu Sato, Toshihiro Sato, Masashi Ninomiya, Jun Inoue, Masamitsu Maekawa, Nariyasu Mano

Summary: A novel liquid chromatography-electrospray ionization tandem mass spectrometry method was developed to accurately measure lenvatinib in human plasma, and it demonstrated good reproducibility. Therefore, MSW combined with this new detection method could serve as a useful microsampling device for lenvatinib therapeutic drug monitoring in patients with HCC.

THERAPEUTIC DRUG MONITORING (2022)

Review Medicine, General & Internal

Small Bowel Endoscopic Features of Eosinophilic Gastroenteritis

Yu Sasaki, Yasuhiko Abe, Naoko Mizumoto, Eiki Nomura, Yoshiyuki Ueno

Summary: Eosinophilic gastroenteritis (EoGE) is a rare digestive disorder characterized by eosinophilic infiltration in the stomach and intestines. The endoscopic findings of EoGE in the small intestine are not well understood, but this literature review identified common findings such as redness, villous atrophy, erosion, ulceration, edema, and stenosis. These findings contribute to the development of EoGE practice.

DIAGNOSTICS (2023)

Review Medicine, General & Internal

Endoscopic Diagnosis of Eosinophilic Esophagitis: Basics and Recent Advances

Yasuhiko Abe, Yu Sasaki, Makoto Yagi, Naoko Mizumoto, Yusuke Onozato, Matsuki Umehara, Yoshiyuki Ueno

Summary: Eosinophilic esophagitis is a chronic immune-mediated inflammatory disease characterized by esophageal dysfunction and intense eosinophil infiltration. The recognition of characteristic endoscopic features and subsequent biopsy are crucial for early diagnosis and treatment, but the diagnostic consistency among endoscopists is still inadequate. Image-enhanced endoscopy holds promise for improving diagnostic efficiency.

DIAGNOSTICS (2022)

Article Pharmacology & Pharmacy

Safety and Effectiveness of Lenvatinib in Patients with Unresectable Hepatocellular Carcinoma in Real-World Clinical Practice: An Observational Post-Marketing Study in Japan

Junji Furuse, Namiki Izumi, Kenta Motomura, Yoshitaka Inaba, Yoshio Katamura, Yasuteru Kondo, Kazuhisa Yabushita, Katsuaki Motoyoshi, Masatoshi Kudo

Summary: This study aimed to evaluate the real-world safety and effectiveness of Lenvatinib for unresectable hepatocellular carcinoma (uHCC) in clinical practice in Japan. Data of 703 uHCC patients were analyzed, and it was found that the treatment response rate and median overall survival of Lenvatinib were similar to or better than the results of the global Phase III REFLECT trial.

DRUGS-REAL WORLD OUTCOMES (2023)

Article Biochemistry & Molecular Biology

Role of Bile-Derived Extracellular Vesicles in Hepatocellular Proliferation after Partial Hepatectomy in Rats

Shinpei Sugahara, Hiroaki Haga, Chisaki Ikeda, Naohiko Makino, Akiko Matsuda, Yasuharu Kakizaki, Kyoko Hoshikawa, Tomohiro Katsumi, Tetsuya Ishizawa, Toshikazu Kobayashi, Keita Maki, Fumiya Suzuki, Ryoko Murakami, Hidenori Sato, Yoshiyuki Ueno

Summary: Despite extensive study on liver regeneration, the impact of bile-derived extracellular vesicles (bile EVs) on hepatocytes remains unclear. Using a rat model of partial hepatectomy (PH), this study found that bile EVs released 12 hours after PH significantly promoted hepatocyte proliferation. Transcriptome analysis revealed an upregulation of genes promoting cell cycle progression in hepatocytes treated with PH24-EVs.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Oncology

Therapeutic Modifications without Discontinuation of Atezolizumab Plus Bevacizumab Therapy Are Associated with Favorable Overall Survival and Time to Progression in Patients with Unresectable Hepatocellular Carcinoma

Takayuki Tokunaga, Masakuni Tateyama, Yasuteru Kondo, Satoshi Miuma, Shiho Miyase, Kentaro Tanaka, Satoshi Narahara, Hiroki Inada, Sotaro Kurano, Yoko Yoshimaru, Katsuya Nagaoka, Takehisa Watanabe, Hiroko Setoyama, Kotaro Fukubayashi, Motohiko Tanaka, Yasuhito Tanaka

Summary: This study aimed to evaluate the impact of therapeutic modifications of atezolizumab plus bevacizumab therapy in patients with unresectable hepatocellular carcinoma (uHCC). Patients with therapeutic modifications other than discontinuation of both drugs had favorable overall survival and time to progression, while those with discontinuation of both drugs had unfavorable outcomes. Modified liver function and immune-related adverse events increased the risk of discontinuation without other therapeutic modifications. Avoiding discontinuation without other therapeutic modifications may be the optimal management for uHCC.

CANCERS (2023)

Article Oncology

A Phase 2, Prospective, Multicenter, Single-arm Trial of Transarterial Chemoembolization Therapy in Combination Strategy with Lenvatinib in Patients with Unresectable Intermediate-stage Hepatocellular Carcinoma: TACTICS-L Trial

Masatoshi Kudo, Kazuomi Ueshima, Issei Saeki, Toru Ishikawa, Yoshitaka Inaba, Naoki Morimoto, Hiroshi Aikata, Nobukazu Tanabe, Yoshiyuki Wada, Yasuteru Kondo, Masahiro Tsuda, Kazuhiko Nakao, Takanori Ito, Tetsuya Hosaka, Yusuke Kawamura, Teiji Kuzuya, Shunsuke Nojiri, Chikara Ogawa, Hironori Koga, Keisuke Hino, Masafumi Ikeda, Michihisa Moriguchi, Takashi Hisai, Kenichi Yoshimura, Junji Furuse, Yasuaki Arai

Summary: The TACTICS-L trial investigated the efficacy and safety of TACE plus lenvatinib in patients with unresectable intermediate-stage HCC. The results showed that LEN-TACE has significant anti-tumor activity and an acceptable safety profile.

LIVER CANCER (2023)

Article Medicine, General & Internal

Switching to Tenofovir Alafenamide Fumarate in Chronic Hepatitis B Patients Who Had Detectable HBV DNA during Treatment with Entecavir

Kosuke Sato, Jun Inoue, Takehiro Akahane, Tomoo Kobayashi, Satoshi Takai, Takuya Nakamura, Toshihiro Sato, Osamu Kimura, Masashi Ninomiya, Tomoaki Iwata, Akitoshi Sano, Mio Tsuruoka, Masazumi Onuki, Satoko Sawahashi, Hirofumi Niitsuma, Atsushi Masamune

Summary: Switching from ETV to TAF may effectively suppress HBV DNA levels in chronic hepatitis B patients with detectable HBV DNA, even at a low level.

TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE (2022)

暂无数据